Knowledge and attitudes towards HIV vaccines among Soweto adolescents

被引：22

作者：

De Bruyn G. ^{[1
]}

Skhosana N. ^{[1
]}

Robertson G. ^{[1
]}

McIntyre J.A. ^{[1
]}

Gray G.E. ^{[1
]}

机构：

[1] Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg

来源：

BMC Research Notes | / 1卷 / 1期

关键词：

Sexual Debut; Trial Participation; Clinical Trial Participation; Vaccine Clinical Trial; Adolescent Participation;

D O I：

10.1186/1756-0500-1-76

中图分类号：

学科分类号：

摘要：

Background: To explore adolescent HIV risk perception, HIV vaccine knowledge, willingness to participate in future HIV vaccine clinical trials, and the factors that influence willingness to participate among high school students in Soweto, South Africa, we recruited school-going youth through randomly selected local high schools. All pupils within the selected schools from whom parental consent and child assent could be obtained were eligible for participation. A self-administered, facilitated questionnaire was completed by all participants. Findings: Perception of adolescent HIV risk was high. Some misconceptions regarding vaccine research were common, particularly regarding placebo and potential eligibility criteria for prophylactic vaccine trials. Of 240 responses to the willingness item, 84 (35%) indicated they were "probably willing" and 126 (52.5%) that they were "definitely willing to participate". There were no significant differences in willingness by gender, age, school grade, or institution. Factors that were rated as "very important" in determining willingness included receiving current information about HIV research [n = 201 (88.9%)], doing something to honour people who have HIV or have died of AIDS [n = 168 (70.9%)], getting free counselling and testing [n = 167 (70.5)], that participants may receive some protection against HIV infection from the vaccine [n = 160 (70.2%)], and improving motivation to avoid risky behaviour [n = 134 (59%)]. Conclusion: Soweto school-going youth report high degrees of willingness to participate in HIV vaccine trials. This may be related to the high levels of adolescent HIV risk perception. Whether hypothetical willingness translates to participation will await data from adolescent HIV vaccine trials. © 2008 de Bruyn et al; licensee BioMed Central Ltd.

引用

共 18 条

[11]

Newman P.A., Duan N., Lee S.J., Rudy E., Seiden D., Kakinami L., Cunningham W., Willingness to participate in HIV vaccine trials: The impact of trial attributes, Preventive Medicine, 44, 6, pp. 554-557, (2007)

[12]

Starace F., Wagner T.M., Luzi A.M., Cafaro L., Gallo P., Rezza G., Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey, AIDS Care, 18, 1, pp. 66-72, (2006)

[13]

Halpern S.D., Metzger D.S., Berlin J.A., Ubel P.A., Who will enroll? Predicting participation in a phase II AIDS vaccine trial, Journal of Acquired Immune Deficiency Syndromes (1999), 27, 3, pp. 281-288, (2001)

[14]

O'Connell J.M., Hogg R.S., Chan K., Strathdee S.A., McLean N., Martindale S.L., Willoughby B., Remis R., Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial, Journal of Acquired Immune Deficiency Syndromes (1999), 31, 5, pp. 521-528, (2002)

[15]

Swartz L., Kagee A., Kafaar Z., Smit J., Bhana A., Gray G., Lesch A., Lindegger G., Milford C., Richter L., Seedat S., Skhosana N., Stein D.J., Social and behavioral aspects of child and adolescent participation in HIV vaccine trials, J Int Assoc Physicians AIDS Care (Chic Ill), 4, 4, pp. 89-92, (2005)

[16]

Shisana O., Rehle T., Simbayi L.C., South African National Household Survey on HIV Prevalence, HIV Incidence, Behaviour, and Commuication Survey, (2005)

[17]

Hays R.B., Kegeles S.M., Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials, J Acquir Immune Defic Syndr Hum Retrovirol, 20, 2, pp. 164-171, (1999)

[18]

Bartholow B.N., MacQueen K.M., Douglas Jr. J.M., Buchbinder S., McKirnan D., Judson F.N., Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men, J Acquir Immune Defic Syndr Hum Retrovirol, 16, 2, pp. 108-115, (1997)

← 1 2 →